Skip to content

Jacobs Engineering

US · J #1092 by market cap Listed 2016
150.62 -3.96 -2.56%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    J.P. Morgan Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $55
    Market Newswire · 2026/11/20
  • Rating change
    J.P. Morgan Maintains Firefly Aerospace(FLY.US) With Buy Rating, Cuts Target Price to $32
    Market Newswire · 2026/11/20
  • Jefferies Maintains J&J Snack Foods(JJSF.US) With Buy Rating, Raises Target Price to $118
    Market Newswire · 2026/11/20
  • Rating change
    J.P. Morgan Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $300
    Market Newswire · 2026/11/20
  • J&T Express-W (01519) repurchased 1.81 million shares on November 20 at a cost of approximately HK$15.6876 million.
    Zhitong Finance · 2026/11/20
  • Rating change
    J.P. Morgan Maintains Alphabet-A(GOOGL.US) With Buy Rating, Maintains Target Price $375
    Market Newswire · 2026/11/20
  • Rating change
    J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $100
    Market Newswire · 2026/11/20
  • Company notice
    California Bancorp | 4: Statement of changes in beneficial ownership of securities-Director Cullen Kevin J.
    SEC · 2026/11/21
  • Memory Market Update: Key Takeaways from the J.P. Morgan TIG Conference
    CSOP · 2026/11/20
  • Lead Independent Director J. Benjamin Nye Sold A Bunch Of Shares In Rapid7
    Simply Wall St · 2026/11/21
  • Company notice
    Arthur J. Gallagher | 144: Notice of proposed sale of securities pursuant to Rule 144
    SEC · 2026/11/21
  • Company notice
    Utz Brands | 4: Statement of changes in beneficial ownership of securities-Officer Kelley William J. JR
    SEC · 2026/11/21
  • Company notice
    4: Statement of changes in beneficial ownership of securities-Officer Farrell Michael J.
    SEC · 2026/11/21
  • Rating change
    J.P. Morgan Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Cuts Target Price to $17
    Market Newswire · 2026/11/20
  • Company notice
    California Bancorp | 4: Statement of changes in beneficial ownership of securities-Director Armanino Andrew J.
    SEC · 2026/11/21
  • Rating change
    J.P. Morgan Maintains Dick's Sporting Goods(DKS.US) With Buy Rating, Maintains Target Price $188
    Market Newswire · 2026/11/20
  • Rating change
    J.P. Morgan Maintains McGraw Hill(MH.US) With Buy Rating, Raises Target Price to $19
    Market Newswire · 2026/11/20
  • Rating change
    J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $69
    Market Newswire · 2026/11/20
  • J.P. Morgan Maintains RIGHTMOVE(RTMVF.US) With Sell Rating, Raises Target Price to $6.11
    Market Newswire · 2026/11/21
  • Rating change
    J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Announces Target Price $30
    Market Newswire · 2026/11/20
  • Company notice
    Fractyl Health | 3: Initial statement of beneficial ownership of securities- Wartell Michael J.
    SEC · 2026/11/7
  • J.P. Morgan Maintains BT GROUP(BTGOF.US) With Buy Rating, Raises Target Price to $4.41
    Market Newswire · 2026/11/7
  • J.P. Morgan Maintains ESAB Corp(ESAB.US) With Buy Rating, Raises Target Price to $97
    Market Newswire · 2026/11/6
  • Company notice
    4: Statement of changes in beneficial ownership of securities-Officer Weiss Glen J.
    SEC · 2026/11/7
  • Company notice
    Levi Strauss & Co. | 4: Statement of changes in beneficial ownership of securities-Director MING JENNY J
    SEC · 2026/11/7

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.

Jacobs Engineering discussion 0 comments

Add a comment